Related Experiment Video
Updated: Apr 6, 2026

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Polymorphisms in host genes encoding NOSII, C-reactive protein, and adhesion molecules thrombospondin and E-selectin
Abstract:
Cytoadherence of Plasmodium falciparum-infected red blood cells (RBCs) in host microvasculature and complex regulation of the immune response are important contributors to the clinical outcome of disease. We tested the association of 23 single nucleotide polymorphisms (SNPs) and a microsatellite repeat in adhesion molecule genes THBS1 and ESEL, and immune regulatory molecule genes NOSII, CRP, and MBL2 with falciparum malaria in populations residing in a malaria-endemic and a non-endemic region of India. The THBS1 haplotype CCCCA (rs1478604, rs7170682, rs2664141, rs12912082, rs3743125) was a risk factor in the endemic region (relative risk = 3.78) and an ESEL SNP (rs5368, His468Tyr) associated with cerebral malaria (CM) [CM vs. non-cerebral malaria (NCM), odds ratio (OR) = 2.23, p = 0.03]. In the non-endemic region, an ESEL 3'UTR SNP (rs5359) associated with enhanced risk of disease (OR = 3.62, p = 1 × 10(-4)) and the CT genotype of the CRP promoter SNP (C/T/A) strongly associated with protection (severe vs. control, OR = 0.29, p = 6 × 10(-5)). Long repeat alleles of the NOSII promoter microsatellite (CCTTT)n exhibited strong association with protection and the NOSII ATG haplotype (rs3729508, rs2297520, rs9282801) was strongly protective against severe malaria in both regions (endemic, severe vs. control, OR = 0.05, p = 0.0001; non-endemic, severe vs. control, OR = 0.3, p = 1 × 10(-5)). Our results suggest differential contribution of variants of the investigated genes in determining the outcome of malaria in Indian populations.
Insights
Genetic variations in adhesion and immune genes influence malaria outcomes. Specific THBS1 and ESEL gene variants increase risk, while NOSII and CRP gene variants offer protection against Plasmodium falciparum malaria.
Area of Science:
- Genetics
- Immunology
- Infectious Diseases
Background:
- Cytoadherence of Plasmodium falciparum-infected red blood cells (RBCs) and immune response regulation are critical to malaria's clinical outcome.
- Understanding genetic factors influencing malaria susceptibility and severity is crucial for disease control.
Purpose of the Study:
- To investigate the association of single nucleotide polymorphisms (SNPs) and microsatellite repeats in THBS1, ESEL, NOSII, CRP, and MBL2 genes with falciparum malaria.
- To determine the role of these genetic variants in disease outcome in Indian populations from endemic and non-endemic regions.
Main Methods:
- Genotyping of 23 SNPs and one microsatellite repeat in adhesion and immune regulatory genes.
- Case-control association studies were conducted in malaria-endemic and non-endemic Indian populations.
- Statistical analysis included relative risk and odds ratios (OR) to assess genetic associations with malaria and its severity.
Main Results:
- A THBS1 haplotype (CCCCA) was identified as a risk factor in the endemic region (RR = 3.78).
- An ESEL SNP (rs5368) was associated with cerebral malaria (OR = 2.23), and another ESEL SNP (rs5359) with increased disease risk in the non-endemic region (OR = 3.62).
- Protective associations were observed for a CRP promoter SNP (CT genotype, OR = 0.29) and NOSII microsatellite alleles and haplotypes against severe malaria in both regions.
Conclusions:
- Genetic variants in THBS1 and ESEL genes are associated with increased risk of falciparum malaria and its severe forms.
- Variants in NOSII and CRP genes demonstrate significant protective effects against severe malaria.
- These findings highlight the differential contribution of investigated gene variants in determining malaria outcomes in Indian populations.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Single Nucleotide Polymorphisms-SNPs
Diversity of Protists II
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Symbiosis
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

